Point72 Asset Management
TNDM icon

Point72 Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

Point72 Asset Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-90,000
Closed -$1.73M – 4586
2026
Q1 		$1.73M Buy
+90,000
New +$1.96M ﹤0.01% 2416

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Point72 Asset Management's TNDM Position: Q2 2026 in Review

Point72 Asset Management increased its Tandem Diabetes Care (TNDM) stake by 45% in Q2 2026, buying an estimated $3.33M and bringing the position to 610,903 shares worth $9.22M. The position accounts for 0.01% of the portfolio, ranked #1338.

Point72 Asset Management first reported a position in TNDM in Q1 2015 and has held it in 28 quarters since. The position peaked at $66.5M in Q1 2022. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Point72 Asset Management held 610,903 shares of Tandem Diabetes Care worth $9.22M as of Q2 2026.
  • Point72 Asset Management bought 190,425 Tandem Diabetes Care shares in Q2 2026, an estimated $3.33M.
  • Tandem Diabetes Care made up 0.01% of Point72 Asset Management's portfolio in Q2 2026, its #1338 holding.
  • Point72 Asset Management first reported a position in Tandem Diabetes Care in Q1 2015 and has held it in 28 quarters since.
  • Point72 Asset Management's Tandem Diabetes Care position peaked at $66.5M in Q1 2022.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.